By Erin Crager, Marketing Intern, Stanford Blood Center
The collateral damage associated with chemotherapy and radiation treatment may soon be a thing of the past. Medical students have traditionally been taught that the body's immune system generally doesn't turn on itself, even in the presence of a tumor. But Ed Engleman, MD and his research team at Stanford Blood Center have developed a method for training the body's immune system to do just that for prostate cancer. Their research over the past eighteen years has opened new doors for potentially curing other forms of cancer, as well.
By Erin Crager, Marketing Intern, Stanford Blood Center A deafening whistle cuts through the crisp morning air of Stanford Blood Center’s (SBC) parking lot, on par with the ear piercing fire alarm that’s just led to the congregation of the...